Hui-hui Chen

Zhuhai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Epitranscriptomics, immunometabolism, and NETosis: unlocking novel mechanisms of traditional Chinese medicine in COPD.

Epitranscriptomics, immunometabolism, and NETosis: unlocking novel mechanisms of traditional Chinese medicine in COPD.

Journal: Frontiers in immunology
Published: June 09, 2026

The Respiratory Epithelial Barrier as an Immunopharmacological Rheostat: From Homeostatic Sentinel to Therapeutic Target in Chronic Lung Disease.

The Respiratory Epithelial Barrier as an Immunopharmacological Rheostat: From Homeostatic Sentinel to Therapeutic Target in Chronic Lung Disease.

Journal: European journal of immunology
Published: January 09, 2026

Necroptosis in asthma: a critical driver of immune dysregulation and airway remodeling.

Necroptosis in asthma: a critical driver of immune dysregulation and airway remodeling.

Journal: Frontiers in immunology
Published: January 09, 2026

lncRNA-EBLN3P promotes triple-negative breast cancer metastasis via activating Wnt/β-catenin signaling pathway.

lncRNA-EBLN3P promotes triple-negative breast cancer metastasis via activating Wnt/β-catenin signaling pathway.

Journal: Discover oncology
Published: December 18, 2025

The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies.

The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies.

Journal: Frontiers in immunology
Published: October 28, 2025

Pyroptosis-immune cell cross talk in asthma: From molecular mechanisms to precision therapeutics.

Pyroptosis-immune cell cross talk in asthma: From molecular mechanisms to precision therapeutics.

Journal: Frontiers in immunology
Published: October 17, 2025

Ferroptosis-immune-metabolic axis in asthma: mechanistic crosstalk, endotype-specific regulation, and translational targeting.

Ferroptosis-immune-metabolic axis in asthma: mechanistic crosstalk, endotype-specific regulation, and translational targeting.

Journal: Frontiers in immunology
Published: October 14, 2025

Cepharanthine Reverses Gefitinib Resistance in NSCLC by Concurrently Inhibiting AKT/P70S6K Survival Signaling and Activating STING-Mediated Immune Response.

Cepharanthine Reverses Gefitinib Resistance in NSCLC by Concurrently Inhibiting AKT/P70S6K Survival Signaling and Activating STING-Mediated Immune Response.

Journal: Chemical biology & drug design
Published: September 02, 2025

Pyroptosis-driven immune dysregulation in COPD: molecular mechanisms and therapeutic implications.

Pyroptosis-driven immune dysregulation in COPD: molecular mechanisms and therapeutic implications.

Journal: Frontiers in immunology
Published: August 15, 2025

Plumbagin Triggers STING Pathway Activation to Suppress Non-Small Cell Lung Cancer Progression.

Plumbagin Triggers STING Pathway Activation to Suppress Non-Small Cell Lung Cancer Progression.

Journal: Chemical biology & drug design
Published: June 26, 2025

Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques.

Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques.

Journal: Frontiers in immunology
Published: May 19, 2025

Ironing out COPD: ferroptosis-driven immune dysregulation, metabolic rewiring, and precision therapeutic opportunities.

Ironing out COPD: ferroptosis-driven immune dysregulation, metabolic rewiring, and precision therapeutic opportunities.

Journal: Frontiers in immunology
Published: May 19, 2025
Showing 1-12 of 15

Last Updated: 09/26/2026